FDA Allows Caraco to Resume Some Operations at Two Michigan Facilities

Washington Drug Letter
Sun Pharmaceuticals’ Caraco unit may resume some of its Detroit and Wixom, Mich., operations after recent FDA inspections show it is in compliance with a 2009 consent decree.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00